جست‌وجوی استاد و پژوهشگر

Maya Andréمشاهده پروفایل

استاد

• Paediatric Intensive Care
• Neonatology
• NK-cell immunology
• +۳ مورد دیگر

PD Dr Maya André serves as Deputy Head of the Paediatric Intensive Care Service (IPS) at the University Children’s Hospital Basel (UKBB) , Switzerland, and is a physician-scientist with venia legendi in Paediatrics from the University of Tübingen. She concurrently directs her own research laboratory at the University Children’s Hospital Tübingen , Department I Haematology & Oncology, focusing on anti-leukaemic NK-cell immunotherapy. Education & Training MD, Universities of Bonn, Freiburg & Vienna (1990-1996) Dr. med., University Children’s Hospital Freiburg – thesis on Valproate and haemostasis (1998) Specialist certificate in Paediatrics (2002) Additional qualification in Paediatric Intensive Care Medicine (2005) Specialisation in Neonatology (2006) Dr. rer. nat., Faculty of Mathematics & Natural Sciences, Tübingen – thesis on Functional conversion of bacterially reprogrammed monocytes (2012) Habilitation & venia legendi in Paediatrics, University of Tübingen – thesis on Donor-patient-specific xenotransplantation model for NK-cell graft-versus-leukaemia reactivity (2016) Research Focus Maya André’s scientific work bridges bedside paediatric intensive care with cutting-edge cellular immunology. Her laboratory pioneered patient-specific zebrafish and murine xenograft models to dissect how natural killer (NK) cells eradicate acute leukaemia. She has advanced the concept of tumor-priming to generate memory-like NK cells with enhanced anti-tumour activity and currently investigates TIGIT-CD155 blockade to potentiate NK-92 and cytokine-induced memory-like NK cell therapies. Her translational studies integrate multi-parameter flow cytometry panels, real-time intravital imaging, and rigorous pre-clinical validation in preparation for first-in-child trials. Scientific Awards & Funding Sponsorship Prize, Society for Neuropaediatrics (1995) Continuous third-party funding since 2010 totalling 1.5 million CHF from: German Research Foundation, Jose-Carreras Foundation, Else-Kröner-Fresenius Foundation, Fortüne Programme (Tübingen), Madeleine-Schickedanz Foundation, German Childhood Cancer Foundation, Manchot Foundation. Professional Memberships German Society for Paediatrics (DGKJ) Reviewer for Blood, Epilepsy, Haematologica, Plos One, International Journal of Cancer, Journal of Leukocyte Biology, Human Immunology, Leukaemia Research Laboratory & Clinical Team She heads a dedicated research group located at the University Children’s Hospital Tübingen, collaborating closely with the Departments of Paediatric Haematology & Oncology and the Centre for Translational Immunology (CTI). The team includes post-doctoral scientists, graduate students, and clinical fellows who straddle bench-to-bedside research pipelines.

Steven Zvi Josefowiczمشاهده پروفایل

دانشیار

• Immunology
• Epigenetics
• Hematopoiesis
• +۳ مورد دیگر

Steven Zvi Josefowicz is an Associate Professor in the Department of Pathology and Laboratory Medicine at Weill Cornell Medical College, Cornell University, where he has been affiliated since 2022. His research integrates immunology, epigenetics, and hematopoiesis, with a focus on reprogramming immune responses for therapeutic applications in cancer and infectious diseases. Education: Ph.D., University of Washington (2010) B.A., University of California, Berkeley (2002) Research Focus: Dr. Josefowicz investigates epigenetic mechanisms governing immune cell function, hematopoietic stem cell behavior, and immune memory. His work spans: Microbial and cancer immunotherapy development SARS-CoV-2/influenza immune responses Transcriptional regulation in inflammation and hematopoiesis Myeloid cell reprogramming in tumor microenvironments Grant Leadership: He directs multiple NIH-funded projects as Principal Investigator, including: "Histone Variant H3.3 as a Transcription Rheostat in the Immune System" (NIAID, 2025–2030) "Central Innate Immune Memory in BCG-Induced Tumor Immunity" (ASH, 2025–2026) "Epigenetic Regulation of Immunity" (Burroughs Wellcome Fund, 2022–2027) External Engagements: Ownership and consulting for Epistemyx Inc.

Kristen W. Lynchمشاهده پروفایل

استاد

• RNA Biology
• Alternative Splicing
• Alternative Polyadenylation
• +۷ مورد دیگر

Kristen W. Lynch, PhD, is the Benjamin Rush Professor of Biochemistry and Chair of the Department of Biochemistry and Biophysics at the Perelman School of Medicine, University of Pennsylvania. She leads research at the Lynch Lab and co-directs the Institute for RNA Innovation , focusing on RNA processing mechanisms in human immune responses. Education: Harvard University (B.A. 1990, Ph.D. 1996) Postdoctoral Training: University of California, San Francisco (1997-2001) Her work bridges RNA splicing , alternative polyadenylation , and gene regulation in immune cells and cancer. She discovered kinase pathways controlling RNA-binding protein (RBP) activity and demonstrated how antigen stimulation and viral infections reprogram splicing networks to modulate immunity. Collaborative studies with oncologists revealed splicing defects phenocopying genetic mutations in leukemias and identified therapeutic vulnerabilities in RNA processing . Her recent publications highlight TREX-2 complex in mRNA export, hnRNP L repressing cryptic exons, and DDX39B structural analysis . Collaborations span RNA-Seq , splicing codes , and epithelial cell post-transcriptional programs . She explores spliceosomal assembly mechanisms and signal-responsive RBPs in T cells and influenza pathogenesis.

Brent Hanksمشاهده پروفایل

دانشیار

• Cancer Immunotherapy
• Tumor Immunology
• Immune Evasion Mechanisms
• +۵ مورد دیگر

Brent Hanks, MD, PhD is an Associate Professor in the Department of Medicine at the University of North Carolina School of Medicine and a member of the UNC Lineberger Comprehensive Cancer Center. He functions as a laboratory-based physician-scientist with clinical responsibilities managing advanced skin cancer patients and those with upper gastrointestinal malignancies. Dr. Hanks leads the Hanks Lab, which focuses on understanding tumor-mediated immune evasion mechanisms and developing strategies to overcome immunotherapy resistance. His research spans tumor-intrinsic mechanisms of immune evasion, tumor-driven manipulation of dendritic cell functionality, and the role of tumor-mediated innate training in immunotherapy resistance and associated toxicities. His work integrates transgenic mouse tumor models, clinical specimens, and bioinformatic approaches to investigate adaptive immunotherapy resistance, dendritic cell tolerization in the tumor microenvironment, EMT-associated tumor immune evasion, and mechanisms contributing to immunotherapy-associated toxicities. This research program aims to translate fundamental biochemical and metabolic pathway discoveries into early-phase clinical trials. Dr. Hanks' scientific contributions have been recognized with numerous prestigious awards including election to the American Society of Clinical Investigation (ASCI) in 2024, the V Foundation 30th Anniversary Gala Therapy Resistance Award, and multiple Young Investigator Awards from major cancer research organizations. His laboratory team includes research faculty, postdoctoral associates, graduate students, and research technicians working collaboratively to advance cancer immunotherapy. The lab has active recruitment for additional postdoctoral associates and graduate students interested in tumor immunology and immunotherapy research.

Yazan Alwarawrahمشاهده پروفایل

استادیار

• Immunometabolism
• T cell biology
• Obesity-related immune dysfunction
• +۴ مورد دیگر

Dr. Yazan Alwarawrah is an Assistant Professor of Pediatrics at the University of North Carolina at Chapel Hill School of Medicine, specializing in Pediatric Endocrinology. His research focuses on the intersection of immunology and metabolism, with particular emphasis on how obesity affects immune function and the development of metabolic interventions for immune-related pathologies. Undergraduate: Al Al-Bayt University, Mafraq, Jordan Master of Science: Yarmouk University, Irbid, Jordan Doctor of Philosophy: Pharmacology, Duke University Dr. Alwarawrah's primary research interests center on immunometabolism, particularly how metabolic pathways regulate immune cell function in obesity and disease states. His work investigates T cell metabolism in the context of obesity-associated immune dysfunction, with specific focus on protective immunity against influenza. He also studies the role of Immunity Related GTPase I (Irgm1) in regulating T cell metabolism and function, and explores metabolic engineering approaches to enhance chimeric antigen receptor (CAR) T cell persistence in tumor microenvironments. His diverse scientific background spans molecular biology, bioinformatics, pharmacology, and immunology. Analysis of Dr. Alwarawrah's publication record reveals a strong focus on the intersection of metabolism and immunity, particularly in obesity contexts. His work spans fundamental mechanisms of immune cell metabolism to translational applications in infectious disease, cancer, and autoimmune conditions. Key themes include T cell metabolic dysfunction in obesity, macrophage metabolism, and pharmacological targeting of metabolic pathways for therapeutic benefit. His research employs diverse approaches including diet-induced obesity mouse models, metabolic and flow cytometric analyses, and pharmacological interventions. Dr. Alwarawrah's research program bridges basic science and clinical applications, with implications for treating obesity-associated pathologies, cancer, and autoimmune diseases through metabolic interventions. His work on T cell metabolism in obesity has particular relevance for understanding impaired immune responses in metabolic disease states. While specific grant information isn't detailed in the provided materials, his research trajectory suggests involvement in NIH-funded projects related to immunometabolism and obesity.

Jane Parkerمشاهده پروفایل

دانشیار

• Plant innate immunity
• Host-microbe interactions
• NLR receptor signalling
• +۶ مورد دیگر

Jane Parker is an Associate Professor at the Institute for Genetics, University of Cologne. She has held prestigious positions including Max-Planck Fellow (2004-2009) and Senior Group Leader at the Max-Planck Institute for Plant Breeding Research. Her career spans institutions like the Sainsbury Laboratory and John Innes Centre, focusing on plant-microbe interactions. Education: BSc in Applied Biology (1st class hons, 1983) from University of Bradford, PhD in Botany/Microbiology (1987) from University of Wales, Swansea. Her research centers on plant innate immunity, NLR receptor signaling, and biotic stress networks. She investigates how plants reprogram transcription during pathogen attacks and studies natural variation in defense mechanisms using Arabidopsis. Jane has received significant recognition, including election to EMBO and the Leopoldina Academy. She serves on editorial boards for Science , Current Opinion in Plant Biology , and Trends in Plant Science . Her leadership roles include co-coordinating the CEPLAS Cluster of Excellence (2013-2018) and reviewing grants for major international funding bodies.

Benoit STIJLEMANSمشاهده پروفایل

استاد پژوهشی

• Immunology
• Myeloid Cell Biology
• Macrophage Biology
• +۶ مورد دیگر

Prof. Dr. Ir. Benoit STIJLEMANS is a Research Professor at Vrije Universiteit Brussel, where he leads research within the Myeloid Cell Immunology Team. His work focuses on the intricate interactions between host immune responses and parasitic infections, particularly African trypanosomiasis, while also exploring applications in cancer immunology. His educational background includes a Bio-engineering degree in Cell- and Gene biotechnology (1989-1995) followed by a PhD in Applied Biological Sciences (1995-2006) focusing on inflammation-associated anaemia in African trypanosomiasis. He progressed from Post-doctoral assistant (2006-2013) to Senior post-doctoral researcher (2014-2020) before becoming a Research Professor in 2020. Dr. STIJLEMANS' research spans immunology, particularly myeloid cell biology, with emphasis on macrophage function in both infectious disease and cancer contexts. His work bridges fundamental immunological mechanisms with translational applications, especially in nanobody technology development. He has made significant contributions to understanding how parasites like Trypanosoma manipulate host immune responses, particularly through the MIF cytokine family, and how these insights can inform cancer immunotherapy approaches. His research integrates molecular, cellular, and systems-level approaches to dissect complex host-pathogen and tumor-immune interactions. His publication record demonstrates consistent productivity with research spanning from 2002 to the present, with recent work focusing on macrophage plasticity, nanobody applications, and the immunological interface between parasitic infections and cancer biology. Development cooperation prize – edition 2006 Dr. STIJLEMANS has established himself as a leading researcher in myeloid cell immunology, with particular expertise in macrophage biology during parasitic infections and cancer. His work on nanobody technology represents an innovative approach to both diagnostics and therapeutics. The Myeloid Cell Immunology Team he is associated with serves as a hub for interdisciplinary research connecting immunology, parasitology, and cancer biology, fostering collaborations that address fundamental questions while seeking practical applications for disease intervention.

Stuart Rushworthمشاهده پروفایل

استاد

• Molecular Haematology
• Cancer Metabolism
• Tumour Microenvironment
• +۱۲ مورد دیگر

Professor Stuart Rushworth is a faculty member at Norwich Medical School, University of East Anglia, where he serves as the scientific group leader for molecular haematology research. His work focuses on the tumour microenvironment in haematological malignancies, particularly Acute Myeloid Leukaemia and Multiple Myeloma, and the impact of infection and ageing on haematopoietic stem cells. Education: Bachelor's Degree – University of Sunderland PhD in Immunology – University of Cambridge Post-doctoral Training – University of Cambridge and University of East Anglia His research explores metabolic reprogramming, mitochondrial transfer, and stromal interactions in cancer. He has made significant contributions to understanding how leukaemia cells exploit the bone marrow microenvironment for survival and proliferation. His studies have identified key mechanisms such as fatty acid release from adipocytes and intercellular mitochondrial transfer via tunnelling nanotubes. His work bridges basic science and clinical translation, with implications for drug resistance and novel therapeutic strategies. The most recent articles highlight trends in immunometabolism, infection-induced haematopoietic stress responses, and metabolic crosstalk in cancer. Key themes include mitochondrial dynamics, metabolic adaptation, and innate immune signaling pathways like STING. His publications appear in high-impact journals such as Cell Reports , Nature Communications , and Blood . He is actively funded by major research bodies including the British Heart Foundation, The Big C Appeal, Academy of Medical Sciences, and BBSRC. While no formal scientific awards are listed in the provided text, his research has led to clinical trials involving BTK inhibitors in myeloma patients. Professor Rushworth mentors several PhD researchers, including Dominic Fowler-Shorten, E. E. Wojtowicz, A. Jibril, J. A. Moore, and J. Mistry. He leads the Rushworth Group, which is part of the Metabolic Health Research Centre at UEA, focusing on metabolic processes in the tumour microenvironment.

Sung Kimمشاهده پروفایل

دانشیار

• Epigenetic regulation of immune responses
• Macrophage biology
• Innate immunity
• +۳ مورد دیگر

Sung Kim is an Associate Professor at The University of Western Ontario, where he leads the Kim Lab (http://www.kimlab-uwo.com/). He holds a PhD from the University of British Columbia and completed his postdoctoral training at The Scripps Research Institute in San Diego. His research focuses on understanding epigenetic and signaling mechanisms governing macrophage responses to microbes, tissue injury, and cancer. His work investigates how macrophages adapt to environmental cues through epigenetic reprogramming, particularly in contexts of immune tolerance (e.g., to commensal bacteria) and immune dysregulation (e.g., in tumors). Key areas include histone acetylation-mediated tolerance to bacterial components like lipopolysaccharides, and transcription factor roles in tumor-associated macrophage behavior. Publications highlight contributions to understanding anthrax toxin pathogenesis, probiotic immunomodulation (via Lactobacillus rhamnosus), and mechanisms of cytokine regulation (e.g., IL-1β, G-CSF). His lab employs genetic, biochemical, and cellular approaches to dissect signaling pathways in macrophage plasticity. Notable research tools include quasi-haploid RAW 264.7 cell mutagenesis systems and in vivo models of colitis and probiotic efficacy. Current projects aim to translate epigenetic insights into therapeutic strategies for inflammatory diseases and cancer immunotherapy.

Pilar Alcaideمشاهده پروفایل

استاد

• Immunology
• Cardiac Physiology
• Vascular Biology
• +۴ مورد دیگر

Pilar Alcaide is a Professor of Immunology at Tufts University School of Medicine. Her research focuses on understanding molecular mechanisms of T lymphocyte trafficking in inflammatory heart diseases, particularly heart failure. She combines immunology, vascular biology, and cardiac physiology to investigate immune-cardiac interactions using mouse models and advanced microscopy techniques. Education: Ph.D. and M.S. in Immunology from Universidad Autónoma de Madrid (Spain) Dr. Alcaide's lab explores how T cell-endothelial interactions contribute to cardiac pathophysiology, with translational goals toward developing immune-based therapeutics. Key areas include: STING signaling in microglial-neuronal interactions Myeloid fatty acid metabolism in HFpEF CXCR3 blockade for immunotherapy myocarditis Her work has been funded by NIH grants (e.g., mechanisms of T cell activation in cardiac fibrosis). Notable awards include the ASIP Cotran Early Career Investigator Award.

Lionel B. Ivashkivمشاهده پروفایل

استاد

• Cytokine Biology
• Inflammatory and Autoimmune Diseases
• Macrophage and Stromal Cell Activation
• +۴ مورد دیگر

Dr. Lionel B. Ivashkiv is a leading academic and physician-scientist, serving as Professor of Medicine and Immunology at Weill Cornell Medicine and holding dual leadership roles as Chief Scientific Officer at Hospital for Special Surgery (HSS) and Director of the David Z. Rosensweig Genomics Research Center at HSS. His research bridges basic science and translational medicine, focusing on cytokine signaling, epigenetic regulation of inflammation, and therapeutic targets for musculoskeletal disorders. Education : MD from Harvard Medical School, Residency at NYU/Bellevue Hospital, Fellowship at Brigham and Women's Hospital Dr. Ivashkiv's laboratory investigates how cytokines like IFN-γ, IFN-α, IL-10, and TNF regulate innate immune and stromal cell functions (macrophages, osteoclasts, synovial fibroblasts). Key themes include: Jak-STAT signaling crosstalk Epigenomic mechanisms in inflammatory gene expression Macrophage reprogramming (priming/tolerance) Autoimmune disease pathogenesis (rheumatoid arthritis, lupus) Translational genomics (RNA-seq, ChIP-seq, ATAC-seq) Precision medicine approaches for individualized therapies His team employs innovative methods combining bacterial artificial chromosomes (BACs) with CRISPR-Cas9 to study human autoimmunity-associated genes like A20/TNFAIP3 . Recent publications highlight discoveries in: Cytokine-driven inflammation in arthritis and implant failure Lipid metabolism regulation in T cells Novel strategies for preventing peri-implant fibrosis Interferon-γ and PGE2-cAMP axis interactions Epigenetic modulation of immune cell phenotypes Mechanosensing in plasmacytoid dendritic cells Scientific honors include election to the Association of American Physicians and American Society for Clinical Investigation , alongside multiple awards from the Arthritis Foundation and NIH . He leads multidisciplinary teams studying clinical challenges such as: Rheumatoid arthritis flares and therapy resistance Orthopedic implant aseptic loosening Total knee replacement complications Spine degeneration and pain

Karl-Johan Malmbergمشاهده پروفایل

استاد

• Natural Killer Cell Biology
• Cancer Immunotherapy
• Precision Immunology
• +۴ مورد دیگر

Karl-Johan Malmberg is a Professor at the University of Oslo , affiliated with the Faculty of Medicine and leading research at the Radiumhospitalet . His work focuses on Natural Killer (NK) cell biology and precision immunotherapy , with a strong emphasis on cancer immunology , HLA-KIR interactions , and cell therapy engineering . He collaborates extensively with the PRIMA - Precision Immunotherapy Alliance and contributes to translational research in hematopoietic stem cell transplantation and solid tumor immunotherapy . Expert in NK cell education and functional reprogramming Develops allogeneic cell therapies for leukemia and multiple myeloma Pioneers single-cell and high-dimensional analysis of immune compartments Recent publications highlight innovations in NK cell migration inhibition via GPR56, NKG2A/C switch receptors , and nanoparticle-enhanced NK cell activation . His team drives computational tools like MetaGate for cytometry data integration. Key affiliations include the Research Council of Norway Center of Excellence (PRIMA) , with a focus on cell therapy translation and tumor immune microenvironment mapping .

Anna E. Beaudinمشاهده پروفایل

دانشیار

• Fetal Hematopoiesis
• Immune Development
• Hematopoietic Stem Cells
• +۴ مورد دیگر

Anna E. Beaudin is an Associate Professor in the Department of Internal Medicine at the University of Utah School of Medicine, holding an adjunct appointment in the Department of Pathology's Division of Microbiology and Immunology. Her research centers on fetal hematopoiesis and its lifelong impact on immune function and disease susceptibility. Her educational background includes: B.A. from Cornell University M.S. from Brown University Ph.D. from Cornell University Dr. Beaudin's work investigates how fetal hematopoietic stem cells generate specialized immune cells that persist into adulthood to maintain tissue homeostasis. She examines how prenatal challenges like infection and nutrition disrupt immune development, leading to conditions such as asthma, metabolic disorders, and hearing loss. Her lab employs single-cell analysis, fate-mapping, and mouse models to uncover mechanisms of developmental hematopoiesis. Recent publications reveal a dominant theme: prenatal inflammation and nutritional factors reprogram hematopoietic stem cells, altering immune cell development and increasing susceptibility to allergic, metabolic, and autoimmune diseases across the lifespan. Key focus areas include tissue-resident macrophages, innate lymphoid cells, and fetal-specific hematopoietic pathways. Her scientific recognition includes: Pew Biomedical Scholars Award Hellman Foundation Award Research is supported by NIH grants and published in high-impact journals including Cell Stem Cell and Blood. As Principal Investigator, she mentors graduate students through the Molecular Biology Program and serves on committees for the International Society of Experimental Hematology and American Society of Hematology. Her work involves extensive collaboration with immunologists, hematologists, and developmental biologists. The Beaudin Lab operates within the University of Utah's Molecular Medicine Program, utilizing advanced genomic and in vivo techniques to explore how early-life events shape lifelong immunity and disease risk.

• Veterinary Immunology
• Infectious Disease Pathogenesis
• Virology
• +۵ مورد دیگر

Jennifer Rudd is an Assistant Professor in the Department of Veterinary Pathobiology at Oklahoma State University's College of Veterinary Medicine. A fully licensed veterinarian with specialization in infectious diseases, she earned her DVM from Oklahoma State University in 2011, practiced small animal medicine for several years, then returned to complete her PhD in Comparative Biomedical Sciences in 2018 with emphasis on innate immune responses to pandemic influenzas and bacterial coinfections. She became an Assistant Professor in 2021 after serving as a Lecturer from 2018-2021. Dr. Rudd's research interests focus on translational animal models of acute SARS-CoV-2 infection, innate immune response and dysfunction after viral pneumonia, influenza pneumonias and bacterial coinfection, Johne's Disease in small ruminants, bovine respiratory disease complex, and scholarship of teaching and learning. Her work demonstrates expertise in veterinary bacteriology, immunology, and virology, with particular emphasis on neutrophil responses to viral infections. Analysis of her 15 most recent publications reveals a strong focus on SARS-CoV-2 research using feline models, with particular attention to variant-specific immune responses, neutrophil dynamics, and metabolic changes during infection. Her work spans virology, immunology, and comparative medicine, consistently emphasizing translational applications for human and animal health. Class of 2023 Outstanding Class Teaching Award (2021) Zoetis Distinguished Veterinary Teacher Award (2021) Class of 2022 Outstanding Class Teaching Award (2020) Class of 2021 Outstanding Class Teaching Award (2019) OSU Graduate Commencement Marshal (2018) Distinguished Graduate Fellowship recipient (2017-2018) Dr. Rudd actively supervises graduate students through PhD Research and Dissertation courses and teaches Veterinary Bacteriology and Mycology to veterinary students. She serves on multiple committees including the OSU CVM Curriculum Revision Committee and Instructional Resources Committee. Her research is supported by significant funding including NIH grants for the Oklahoma Center for Respiratory and Infectious Diseases and projects on Johne's Disease diagnostics in small ruminants.

Matthieu Defranceمشاهده پروفایل

دانشیار

• Gene Regulation
• Epigenetics
• Epigenomics
• +۶ مورد دیگر

Matthieu Defrance is an Associate Professor in the Computer Science Department at Université Libre de Bruxelles (ULB), Belgium, a position he has held since October 2016. Prior to this, he worked as a PostDoc at ULB's Laboratory of Cancer Epigenetics from May 2010 to September 2016. Dr. Defrance's research bridges computer science with biological sciences, focusing on computational methods for analyzing complex biological data. His work spans epigenetics, genomics, and algorithm development for biological applications. His primary research interests include: Gene Regulation and Chromatin Biology Epigenetics and Epigenomics DNA Methylation analysis Computational Statistics for biological data Algorithm Development for genomic applications Next Generation Sequencing data analysis Dr. Defrance's publication record demonstrates a strong interdisciplinary approach, with recent work focusing on improving DNA methylation analysis techniques, developing novel bioinformatics tools like RedRibbon for gene expression signature comparison, and applying these methods to understand diseases like diabetes and cancer. His research shows consistent innovation in computational biology, with publications spanning from method development to biological applications across diverse fields including diabetes genetics, cancer epigenetics, and evolutionary adaptations in desert ants. With 61 publications and nearly 5,000 citations, Dr. Defrance has established himself as a significant contributor to computational biology and epigenetics research.